Mid-term results of heart transplantation in diabetic patients.

Source:http://linkedlifedata.com/resource/pubmed/id/7775522

Download in:

View as

General Info

Authors

Thiene G, Grassi G, Boffa GM, Live I, Casarotto D, Bianco R, Caforio AL, Gambino A, Milano A, Casula R

Affiliation

Department of Cardiovascular Surgery, University of Padova Medical School, Italy.

Abstract

Diabetes mellitus (DM) has been considered a relative contraindication to heart transplantation (HTx) because of possible increased infection rates and worsening DM with prednisone immunosuppression. The introduction of cyclosporine has allowed us to reduce the dosage of oral steroids and to accept DM patients (pts) for HTx. We reviewed the mid-term outcome of our DM pts who had undergone HTx.

PMID
7775522